A multicenter, randomized, single-blind, 2-arm intervention study evaluating the adverse events and quality of life after irreversible electroporation for the ablation of localized low-intermediate risk prostate cancer. Reply.
| dc.authorid | 0000-0003-0906-4417 | |
| dc.authorid | 0000-0002-6308-1763 | |
| dc.contributor.author | Zhang, Kai | |
| dc.contributor.author | Teoh, Jeremy | |
| dc.contributor.author | del Pilar Laguna Pes, Maria | |
| dc.contributor.author | Ng, Chi-Fai | |
| dc.contributor.author | de la Rosette, Jean J. M. C. H. | |
| dc.date.accessioned | 2023-04-25T13:33:16Z | |
| dc.date.available | 2023-04-25T13:33:16Z | |
| dc.date.issued | 2023 | |
| dc.department | İstanbul Medipol Üniversitesi, Uluslararası Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Üroloji Ana Bilim Dalı | |
| dc.description.abstract | To the Editor: We appreciate this opportunity toaddress the concerns in the comment by Jin et al on ourarticle,1evaluating the adverse events and quality of lifeafter irreversible electroporation (IRE) for the ablationof localized low-intermediate risk prostate cancer. | |
| dc.identifier.citation | Zhang, K., Teoh, J., del Pilar Laguna Pes, M., Ng, C. ve de la Rosette, J. J. M. C. H. (2023). A multicenter, randomized, single-blind, 2-arm intervention study evaluating the adverse events and quality of life after irreversible electroporation for the ablation of localized low-intermediate risk prostate cancer. Reply. Journal of Urology, 209(5), 847-848. https://dx.doi.org/10.1097/JU.0000000000003405 | |
| dc.identifier.doi | 10.1097/JU.0000000000003405 | |
| dc.identifier.endpage | 848 | |
| dc.identifier.issn | 0022-5347 | |
| dc.identifier.issn | 1527-3792 | |
| dc.identifier.issue | 5 | |
| dc.identifier.pmid | 36927010 | |
| dc.identifier.scopus | 2-s2.0-85152172396 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | 847 | |
| dc.identifier.uri | https://dx.doi.org/10.1097/JU.0000000000003405 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12511/10889 | |
| dc.identifier.volume | 209 | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.institutionauthor | del Pilar Laguna Pes, Maria | |
| dc.institutionauthor | de la Rosette, Jean J. M. C. H. | |
| dc.language.iso | en | |
| dc.publisher | Wolters Kluwer Health | |
| dc.relation.ispartof | Journal of Urology | en_US |
| dc.relation.publicationcategory | DiÄŸer | |
| dc.rights | info:eu-repo/semantics/embargoedAccess | |
| dc.subject | Prostate Cancer | |
| dc.subject | Irreversible Electroporation | |
| dc.subject | Ablation of Localized | |
| dc.title | A multicenter, randomized, single-blind, 2-arm intervention study evaluating the adverse events and quality of life after irreversible electroporation for the ablation of localized low-intermediate risk prostate cancer. Reply. | |
| dc.type | Letter |
Dosyalar
Orijinal paket
1 - 1 / 1
Küçük Resim Yok
- İsim:
- Laguna-Pilar-2023.pdf
- Boyut:
- 133.56 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text
Lisans paketi
1 - 1 / 1
Küçük Resim Yok
- İsim:
- license.txt
- Boyut:
- 1.44 KB
- Biçim:
- Item-specific license agreed upon to submission
- Açıklama:











